Streetbeat News

Equity Actions

SLDB

Solid Biosciences Inc. (NASDAQ:SLDB) has announced a private placement of approximately $108.9 million, selling 16.97 million shares and pre-funded warrants to fund its pipeline development programs. The placement is expected to close on January 11, 2024, and is in compliance with Nasdaq rules. The proceeds will support ongoing development, business activities, working capital, and other corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:20 pm

IMNM

ZNTL

Immunome and Zentalis Pharmaceuticals have entered into an exclusive, worldwide license agreement. Zentalis will receive an initial payment of $35 million in cash and Immunome common stock, with the potential to earn up to $275 million in milestone payments for ZPC-21 and the platform technology. Additionally, Zentalis is set to receive mid-to-high single-digit royalties.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:15 pm

AWI

Armstrong World Industries, Inc. (AWI) has formed a strategic partnership with McKinstry by investing in Overcast Innovations, which specializes in integrated building solutions. This partnership aims to leverage Armstrong's ceiling solutions and market reach to accelerate Overcast's growth, addressing challenges such as labor shortages and the need for energy-efficient designs in the construction industry.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:15 pm

AMC

CRGE

GMM

The article discusses three oversold tech and telecom stocks with RSI values near or below 30, indicating potential undervaluation. Global Mofy Metaverse Limited (GMM) announced a $10 million follow-on offering, with its stock falling 51% over five days. AMC Entertainment Holdings, Inc. (AMC) disclosed exchange agreements for its common stock in exchange for $22.5 million of its subordinated notes, with its stock falling 17% over five days. Charge Enterprises, Inc. (CRGE) reported downbeat quarterly sales but highlighted growth in its Infrastructure segment, with its stock falling 28% over the past month.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 12:13 pm

RLAY

Relay Therapeutics has entered into a private placement financing agreement with NexTech, agreeing to sell 2.5 million shares at a price of $12.00 per share. This deal will result in gross proceeds of $30 million for Relay Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:06 pm

ECL

Analysts have provided varying ratings for Ecolab (NYSE:ECL) over the last quarter, with sentiments ranging from bullish to bearish. In the past 30 days, there have been no changes in ratings, maintaining 4 somewhat bullish and 1 indifferent stance from previous months. The 12-month price target for ECL has an average of $208.4, with a high of $213.00 and a low of $193.00, marking an 11.44% increase from the previous average of $187.00. Ecolab is a leader in cleaning and sanitation products with strong market presence and financial performance, including a 7.87% revenue growth rate and a net margin of 10.21%, but faces challenges with a high debt-to-equity ratio of 1.17.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 12:01 pm

GPN

Global Payments (NYSE:GPN) has been evaluated by 11 analysts over the last three months, with a mix of bullish to bearish sentiments. The average 12-month price target is $142.73, with a high of $180.00 and a low of $110.00, marking a 10.07% decrease from the previous average. Analysts have made various rating changes and price target adjustments, reflecting their views on the company's performance and market conditions. Global Payments is a payment processing and software solutions provider, with a recent revenue growth of 8.33% as of September 30, 2023. However, it has a lower market capitalization, below-average ROE and ROA, and a prudent debt-to-equity ratio of 0.77.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 12:00 pm

USFD

US Foods Holding has reaffirmed its fiscal year 2023 guidance, maintaining its adjusted diluted EPS forecast at $2.60-$2.70 and its adjusted EBITDA prediction at $1.54-$1.56 billion, as previously announced on its Q3 earnings call on November 9, 2023.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:00 pm

SAGE

Sage Therapeutics has announced the retirement of Kevin Starr from its Board of Directors. Geno Germano has taken over as the new Chair of the Board. This change in leadership may influence the company's strategic direction and governance.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:38 am

NPO

Enpro Industries, Inc. has announced that Joseph F. Bruderek Jr. will take over as CFO effective April 1, 2024, following the retirement of current CFO J. Milton Childress II. Bruderek has already joined the company as Executive Vice President, Finance. Childress will continue in his role until the transition date and will remain with the company until May 31, 2024, to assist with the transition.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:32 am